Long-term radiation-related health effects in a unique human population: Lessons learned from the atomic bomb survivors of Hiroshima and nagasaki

Disaster Medicine and Public Health Preparedness

Volumn 5, Issue SUPPL. 1, 2011, Pages

  Douple, Evan B ^a   Mabuchi, Kiyohiko ^b   Cullings, Harry M ^a   Preston, Dale L ^c   Kodama, Kazunori ^a   Shimizu, Yukiko ^a   Fujiwara, Saeko ^a   Shore, Roy E ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Hirosoft International ^*  (United States)

Author keywords

Atomic bomb; Cancer; Epidemiology; Excess relative risks; Genetics; Health effects; Ionizing radiation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATOMIC BOMB; ATOMIC WARFARE; CARDIOVASCULAR DISEASE; CHILD; COHORT ANALYSIS; DNA DAMAGE; FEMALE; HUMAN; INFANT; IONIZING RADIATION; JAPAN; MALE; MIDDLE AGED; MORTALITY; NEWBORN; NUCLEAR ACCIDENT; ORGANIZATION AND MANAGEMENT; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; RADIATION INDUCED NEOPLASM; RADIATION INJURY; RADIATION RESPONSE; RADIOMETRY; RESEARCH; RISK ASSESSMENT; SURVIVOR; THYROID DISEASE; WAR;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; NUCLEAR WEAPONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RADIATION INJURIES; RADIATION, IONIZING; RADIOACTIVE HAZARD RELEASE; RADIOMETRY; RESEARCH; RISK ASSESSMENT; SURVIVORS; THYROID DISEASES; WORLD WAR II;

EID: 79953000655     PISSN: 19357893     EISSN: 1938744X     Source Type: Journal    
DOI: 10.1001/dmp.2011.21     Document Type: Review

References (79)

1. The Committee for the Compilation of Materials on Damage Caused by the Atomic Bombs in Hiroshima and Nagasaki. Hiroshima and Nagasaki: The Physical, Medical, and Social Effects of the Atomic Bombings. New York: Basic Books; 1981.
2. Shirabe R. Statistical Observations of Atomic Bomb Casualties in Nagasaki. In: Shibata Y, ed. Nagasaki, Japan: Showado Inc; 2006.
3. Yasuyama K. Collection of Memoirs of the Atomic Bombardment of Nagasaki 1945-55. In: Yamashita S, ed. Nagasaki, Japan: Heiwadou Offset; 2005.
4. Beebe FW. Reflections on the work of the atomic bomb casualty commission in Japan. Epidemiol Rev. 1979;1:184-210.
5. Neel JV, Schull WJ. The Effect of Exposure to the Atomic Bombs on Pregnancy Termination in Hiroshima and Nagasaki. Washington, DC: National Academy of Sciences/National Research Council; 1956.
6. Francis TJ, Jablon S, Moore FE. Report of an Ad Hoc Committee for Appraisal of the ABCC Program 1955. Hiroshima, Japan: Atomic Bomb Casualty Commission; 1959.
7. Beebe G, Usagawa M. The Major ABCC Samples. Hiroshima, Japan: Atomic Bomb Casualty Commission; 1968.
8. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950- 1990. Radiat Res. 1996;146(1):1-27. (Pubitemid 26230829)
9. Mabuchi K, Soda M, Ron E, et al. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 1994;137(2)(Suppl):S1-S16. (Pubitemid 24060245)
10. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res. 1994;137 (2)(Suppl):S17-S67. (Pubitemid 24060246)
11. Lindee MS. Suffering Made Real: American Science and the Survivors at Hiroshima. Chicago: University of Chicago Press; 1994.
12. Schull WJ. Effects of Atomic Radiation: A Half-century of Studies from Hiroshima and Nagasaki. New York:Wiley-Liss; 1995.
13. Reassessment of the Atomic Bomb Radiation Dosimetry forHiroshima and Nagasaki- Dosimetry System 2002. Hiroshima, Japan: Radiation Effects Research Foundation; 2005.
14. Reassessment of the Atomic Bomb Radiation Dosimetry forHiroshima and Nagasaki- Dosimetry System 1986. Final Report. Hiroshima, Japan: Radiation Effects Research Foundation; 1987.
15. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: Its evolution and present status. Radiat Res. 2006;166:219-254. (Pubitemid 44051213)
16. National Research Council, Committee on Dosimetry for the Radiation Effects Research Foundation. Status of the Dosimetry for the Radiation Effects Research Foundation (DS86). Washington, DC: National Academy Press; 2001.
17. Eden L. Whole World on Fire: Organizations, Knowledge, and Nuclear Weapons Devastation. Ithaca, NY: Cornell University Press; 2003.
18. Glasstone S, Dolan PJ, eds. The Effects of Nuclear Weapons. 3rd ed. Washington, DC: US Government Printing Office; 1977.
19. Solomon F, Marston RQ, eds. The Medical Implications of Nuclear War. Washington, DC: National Academy Press; 1986.
20. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 1990;123 (3):275-284. (Pubitemid 20327898)
21. Kodama Y, Pawel DJ, Nakamura N, et al. Stable chromosome aberrations in atomic bomb survivors: Results from 25 years of investigation. Radiat Res. 2001;156(4):337-346. (Pubitemid 32904987)
22. Nakamura N, Miyazawa C, Sawada S, Akiyama M, Awa AA.Aclose correlation between electron spin resonance (ESR) dosimetry from tooth enamel and cytogenetic dosimetry from lymphocytes of Hiroshima atomicbomb survivors. Int J Radiat Biol. 1998;73(6):619-627. (Pubitemid 28320032)
23. Mabuchi K, Fujiwara S, Preston DL, et al. Atomic-bomb survivors: Longterm health effects of radiation. In: Shrieve DC, Loeffler JS, eds. Human Radiation Injury. Philadelphia: Lippincott Williams & Wilkins; 2011:89-113.
24. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007;168(1):1-64. (Pubitemid 351292925)
25. Finch SC, Hrubec Z, Nefzger MD, et al. Detection of Leukemia and Related Disorders. Hiroshima and Nagasaki Research Plan. Hiroshima, Japan: Atomic Bomb Casualty Commission; 1965.
26. Furukawa K, Cologne JB, Shimizu Y, Ross NP. Predicting future excess events in risk assessment. Risk Anal. 2009;29(6):885-899.
27. Preston DL, Pierce DA, Shimizu Y, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res. 2004;162(4):377-389. (Pubitemid 39388159)
28. Richardson D, Sugiyama H, Nishi N, et al. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res. 2009;172(3):368-382.
29. Iwanaga M, Hsu W-L, Soda M, et al. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: A retrospective cohort study of nagasaki atomic bomb survivors. J Clin Oncol. 2011;29(4):428-434.
30. Preston DL, Shimizu Y, Pierce DA, SuyamaA,Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160(4):381-407. (Pubitemid 37174507)
31. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: National Research Council; 2005.
32. United Nations Scientific Committee on the Effects of Atomic Radiation. Effects of Ionizing Radiation. UNSCEAR 2006 Report. Report to the General Assembly with Scientific Annexes A and B. New York: United Nations Scientific Committee on the Effects of Atomic Radiation; 2008.
33. International Commission on Radiological Protection. ICRP Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. Oxford, UK: Elsevier; 2007.
34. Suzuki G, Cullings H, Fujiwara S, et al. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1224-1228. (Pubitemid 46984963)
35. Sauvaget C, Lagarde F, Nagano J, Soda M, Koyama K, Kodama K. Lifestyle factors, radiation and gastric cancer in atomic-bomb survivors ( Japan). Cancer Causes Control. 2005;16(7):773-780. (Pubitemid 41160041)
36. Cogan DG, Martin SF, Kimura SJ. Atom bomb cataracts. Science. 1949; 110(2868):654.
37. Miller RJ, Fujino T, Nefzger MD. Lens findings in Atomic bomb survivors. A review of major ophthalmic surveys at the atomic Bomb Casualty Commission (1949-1962). Arch Ophthalmol. 1967;78(6):697-704.
38. Choshi K, Takaku I, Mishima H, et al. Ophthalmologic changes related to radiation exposure and age in adult health study sample, Hiroshima and Nagasaki. Radiat Res. 1983;96(3):560-579. (Pubitemid 14183183)
39. Otake M, Neriishi K, Schull WJ. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation. Radiat Res. 1996;146(3):339-348. (Pubitemid 26320100)
40. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. Oxford, UK: Pergamon Press; 1990.
41. National Council on Radiation Protection and Measurements. Limitations of Exposure to Ionizing Radiation. Report 116. Bethesda, MD: National Council on Radiation Protection and Measurements; 1993.
42. Neriishi K, Nakashima E, MinamotoA, et al. Postoperative cataract cases among atomic bomb survivors: Radiation dose response and threshold. Radiat Res. 2007;168(4):404-408. (Pubitemid 351303167)
43. ImaizumiM, Usa T, Tominaga T, et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA. 2006;295(9):1011-1022.
44. Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of the mortality of Abomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res. 1992;130(2):249-266.
45. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950- 1990. Radiat Res. 1999;152(4):374-389. (Pubitemid 29463615)
46. Wong FL, Yamada M, Sasaki H, et al. Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiat Res. 1993;135(3):418-430. (Pubitemid 23306530)
47. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 2004; 161(6):622-632. (Pubitemid 39149570)
48. Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010; Jan 14;340:b5349 (doi:10.1136/bmj.65349).
49. Sasaki H, Wong FL, Yamada M, Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J Clin Epidemiol. 2002;55(10):974-981. (Pubitemid 36018861)
50. Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res. 1999;151(6):736-746. (Pubitemid 29252562)
51. Akahoshi M, Amasaki Y, Soda M, et al. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens Res. 2003;26(12):965-970. (Pubitemid 38128769)
52. Neriishi K, Matuso N, Ishimaru T, et al. Relationship between radiation exposure and serum protein alpha and beta globulin fractions. Nagasaki Med J. 1986;61:449-454.
53. Sawada H, Kodama K, Shimizu Y, et al. Adult Health Study Report 6. Results of Six Examination Cycles, 1968-1980. Hiroshima and Nagasaki: Radiation Effects Research Foundation; 1986.
54. Neriishi K, Nakashima E, Delongchamp RR. Persistent subclinical inflammation among A-bomb survivors. Int J Radiat Biol. 2001;77(4):475-482. (Pubitemid 32281128)
55. Hayashi T, Kusunoki Y, Hakoda M, et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int J Radiat Biol. 2003;79(2):129-136. (Pubitemid 36183071)
56. Lifton RJ. Death in Life-Survivors of Hiroshima. New York: Random House; 1967.
57. Yamada M, Izumi S. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions. Soc Psychiatry Psychiatr Epidemiol. 2002;37(9):409-415. (Pubitemid 36076018)
58. Cologne JB, Preston DL. Longevity of atomic-bomb survivors. Lancet. 2000; 356(9226):303-307. (Pubitemid 30459589)
59. Kusunoki Y, Yamaoka M, Kubo Y, et al. T-cell immunosenescence and inflammatory response in atomic bomb survivors. Radiat Res. 2010;174 (6):870-876.
60. Kusunoki Y, Hirai Y, Hakoda M, Kyoizumi S. Uneven distributions of naïve and memory T cells in the CD4 and CD8 T-cell populations derived from a single stem cell in an atomic bomb survivor: Implications for the origins of the memory T-cell pools in adulthood. Radiat Res. 2002;157(5):493-499. (Pubitemid 34492555)
61. Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: Implications for disease development among atomic bomb survivors. Int J Radiat Biol. 2008;84(1):1-14. (Pubitemid 350208779)
62. Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992. Radiat Res. 1997;147(3):385-395.
63. Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100(6):428-436. (Pubitemid 351480515)
64. Jablon S, Kato H. Childhood cancer in relation to prenatal exposure to atomic-bomb radiation. Lancet. 1970;2(7681):1000-1003.
65. Otake M, Schull WJ. In utero exposure to A-bomb radiation and mental retardation; a reassessment. Br J Radiol. 1984;57(677):409-414. (Pubitemid 14129700)
66. Otake M, SchullWJ, Lee S. Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: A re-analysis. Int J Radiat Biol. 1996;70(6):755-763. (Pubitemid 26426814)
67. Schull WJ, Nishitani H, Hasuo K, et al. Brain Abnormalities Among the Mentally Retarded Prenatally Exposed Atomic Bomb Survivors. RERF Technical Report 13-91. Hiroshima, Japan: Radiation Effects Research Foundation; 1991.
68. International Commission on Radiological Protection. Biological effects after prenatal irradiation (embryo and fetus). Publication 90. Ann ICRP. 2003;33:1-200.
69. SchullWJ, Norton S, Jensh RP. Ionizing radiation and the developing brain. Neurotoxicol Teratol. 1990;12(3):249-260. (Pubitemid 20344189)
70. Dunn K, Yoshimaru H, Otake M, Annegers JF, Schull WJ. Prenatal exposure to ionizing radiation and subsequent development of seizures. Am J Epidemiol. 1990;131(1):114-123. (Pubitemid 20014704)
71. National Academy of Sciences. The Children of Atomic Bomb Survivors. A Genetic Study. Washington, DC: National Academy Press; 1991.
72. Awa AA, Bloom AD, Yoshida MC, Meriishi S, Archer PG. Cytogenetic study of the offspring of atom bomb survivors. Nature. 1968;218(5139): 367-368.
73. Neel JV, Satoh C, Goriki K, et al. Search for mutations altering protein charge and/or function in children of atomic bomb survivors: Final report. Am J Hum Genet. 1988;42(5):663-676.
74. Nakamura N. Genetic effects of radiation in atomic-bomb survivors and their children: Past, present and future. J Radiat Res (Tokyo). 2006;47 (Suppl B):B67-B73. (Pubitemid 44535107)
75. Kato H, Schull WJ, Neel JV. A cohort-type study of survival in the children of parents exposed to atomic bombings. Am J Hum Genet. 1966; 18(4):339-373.
76. Yoshimoto Y, Neel JV, SchullWJ, et al. Malignant tumors during the first 2 decades of life in the offspring of atomic bomb survivors.AmJ Hum Genet. 1990;46(6):1041-1052.
77. Izumi S, Koyama K, Soda M, Suyama A. Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs. Br J Cancer. 2003;89(9):1709-1713. (Pubitemid 37464144)
78. Izumi S, Suyama A, Koyama K. Radiation-related mortality among offspring of atomic bomb survivors: A half-century of follow-up. Int J Cancer. 2003;107(2):292-297. (Pubitemid 37152913)
79. Fujiwara S, Suyama A, Cologne JB, et al. Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivors. Radiat Res. 2008;170(4):451-457.